Alf Kastbom
Senior Associate Professor
My research group works to detect rheumatoid arthritis before the disease has broken out and to understand the mechanisms behind it. This would open up the possibility of being able to prevent the disease in the future.
CV
Complete CV
Publications
2026
Certolizumab pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: 48-week patient-reported outcomes from the NORD-STAR trial
The Lancet Rheumatology, Vol. 8, p. e285-e294
(Article in journal)
https://dx.doi.org/10.1016/S2665-9913(26)00007-X
Autoantibodies as predictors of progression to rheumatoid arthritis: a systematic review and meta-analysis
RMD Open, Vol. 12, Article e006368
(Article in journal)
https://dx.doi.org/10.1136/rmdopen-2025-006368
Mucosal innate immune activation as the trigger to Prevotella species-induced arthritis in genetically resistant mice
Cell Reports, Vol. 45, Article 116755
(Article in journal)
https://dx.doi.org/10.1016/j.celrep.2025.116755
2025
Work loss in patients with rheumatoid arthritis treated with abatacept, rituximab, tocilizumab or TNF inhibitors: a nationwide direct drug-to-drug comparison
RMD Open, Vol. 11, Article e004936
(Article in journal)
https://dx.doi.org/10.1136/rmdopen-2024-004936
Autoantibodies against pentraxin-3 in systemic lupus erythematosus: mapping of reactivity to linear epitopes and associations with disease variables
Autoimmunity, Vol. 58, Article 2579832
(Article in journal)
https://dx.doi.org/10.1080/08916934.2025.2579832